Drug Safety Project


View All
  • Stakeholder Requirements: Drug Supply Chain Security Act

    A closer look at the stakeholder requirements for the Drug Supply Chain Security Act as defined by Title II of the act. Requirements are broken down by each segment of the supply chain: manufacturers, re-packagers, wholesale distributors and dispensers. Read More

  • Timeline for the Drug Supply Chain and Security Act

    The Drug Supply Chain and Security Act (Title II, Drug Quality and Security Act, 2013) addresses risks in the pharmaceutical distribution supply chain by establishing a national system that allows stakeholders and regulators to trace each package of product. Read More

  • A Look Into U.S. Drug Supply Safety

    In late 2007, U.S. health officials began receiving reports of unexpected allergic-type reactions in patients undergoing dialysis. The reactions were linked to a widely used blood thinner—heparin—and specifically to an adulterant that had been introduced during manufacture of the drug in China. The U.S. Food and Drug Administration (FDA) believes the adulteration of heparin was an economically... Read More

Media Contact

Linda Paris

Officer, Communications